Loading…

Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction

The prognostic implications of cardiovascular magnetic resonance imaging (CMR)-derived hyperemic myocardial blood flow (MBF) in patients with ST-elevation myocardial infarction (STEMI) are unknown. This study sought to investigate the incremental prognostic value of hyperemic MBF over conventional C...

Full description

Saved in:
Bibliographic Details
Published in:Heart and vessels 2020-07, Vol.35 (7), p.936-945
Main Authors: Hamaya, Rikuta, Kanaji, Yoshihisa, Hada, Masahiro, Kanno, Yoshinori, Usui, Eisuke, Hoshino, Masahiro, Yamaguchi, Masao, Sumino, Yohei, Horie, Tomoki, Hirano, Hidenori, Sugiyama, Tomoyo, Kakuta, Tsunekazu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c399t-2a001b4e79fe4477491ab4e172469a0397be00112acff7396fe8a6eac8945a0b3
cites cdi_FETCH-LOGICAL-c399t-2a001b4e79fe4477491ab4e172469a0397be00112acff7396fe8a6eac8945a0b3
container_end_page 945
container_issue 7
container_start_page 936
container_title Heart and vessels
container_volume 35
creator Hamaya, Rikuta
Kanaji, Yoshihisa
Hada, Masahiro
Kanno, Yoshinori
Usui, Eisuke
Hoshino, Masahiro
Yamaguchi, Masao
Sumino, Yohei
Horie, Tomoki
Hirano, Hidenori
Sugiyama, Tomoyo
Kakuta, Tsunekazu
description The prognostic implications of cardiovascular magnetic resonance imaging (CMR)-derived hyperemic myocardial blood flow (MBF) in patients with ST-elevation myocardial infarction (STEMI) are unknown. This study sought to investigate the incremental prognostic value of hyperemic MBF over conventional CMR markers to identify patients with high risk of future incidence of patient-oriented composite outcomes (POCO) and major adverse cardiac events (MACE) after STEMI. A total of 237 patients who presented with STEMI were prospectively enrolled. The CMR protocol included left-ventricular ejection fraction (LVEF), late gadolinium enhancement (LGE) and microvascular obstruction (MVO) measurement, and volumetric MBF assessment. During a median follow-up of 2.6 years, 47 patients experienced POCO (primary outcome) and 21 patients had MACE. In a multivariable model, multivessel disease, LGE, MVO, and hyperemic MBF were independently associated with POCO. Addition of hyperemic MBF to the model consisting of GRACE score, multivessel disease, LVEF, LGE, and MVO significantly improved the predictive efficacy (integrated discrimination improvement 0.020, p  = 0.021). Patients with low hyperemic MBF had significantly higher incidence of MACE compared to those with high hyperemic MBF in propensity score matching analysis ( p  = 0.018). In conclusion, CMR-derived hyperemic MBF could provide independent and incremental prognostic value over LVEF, LGE, and MVO in patients with STEMI.
doi_str_mv 10.1007/s00380-020-01570-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2366641925</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2366641925</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-2a001b4e79fe4477491ab4e172469a0397be00112acff7396fe8a6eac8945a0b3</originalsourceid><addsrcrecordid>eNp9kUtPGzEUha2qqITQP8ACWeqGzbR-zXi8RFEplZCoRFhbHscOjjzjYE-K-Pe96aQUsUDy8_o7x1c6CJ1R8pUSIr8VQnhLKsJg0lqSqv2AZrShdcVqyT-iGVEUipzJY3RSyoYApaj6hI45o4TDMkP5V07rIZUxWBz6bQzWjCENOHm8jqkzEffPyZq8CnDsYkor7GN6wmHAWyDdMBb8FMYHfLesilv3UMAuut-TyyttGLzJdl89RUfexOI-H_Y5ur_6vlxcVze3P34uLm8qy5UaK2ag3044qbwTQkqhqIErlUw0yhCuZOeAoMxY7yVXjXetaZyxrRK1IR2fo4vJd5vT486VUfehWBejGVzaFc140zSCKlYD-uUNukm7PEB3mgkiGyJgAMUmyuZUSnZeb3PoTX7WlOh9InpKREMi-m8iugXR-cF61_Vu9SL5FwEAfAIKPA1rl____Y7tH67Tl0g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2407604604</pqid></control><display><type>article</type><title>Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction</title><source>Springer Nature</source><creator>Hamaya, Rikuta ; Kanaji, Yoshihisa ; Hada, Masahiro ; Kanno, Yoshinori ; Usui, Eisuke ; Hoshino, Masahiro ; Yamaguchi, Masao ; Sumino, Yohei ; Horie, Tomoki ; Hirano, Hidenori ; Sugiyama, Tomoyo ; Kakuta, Tsunekazu</creator><creatorcontrib>Hamaya, Rikuta ; Kanaji, Yoshihisa ; Hada, Masahiro ; Kanno, Yoshinori ; Usui, Eisuke ; Hoshino, Masahiro ; Yamaguchi, Masao ; Sumino, Yohei ; Horie, Tomoki ; Hirano, Hidenori ; Sugiyama, Tomoyo ; Kakuta, Tsunekazu</creatorcontrib><description>The prognostic implications of cardiovascular magnetic resonance imaging (CMR)-derived hyperemic myocardial blood flow (MBF) in patients with ST-elevation myocardial infarction (STEMI) are unknown. This study sought to investigate the incremental prognostic value of hyperemic MBF over conventional CMR markers to identify patients with high risk of future incidence of patient-oriented composite outcomes (POCO) and major adverse cardiac events (MACE) after STEMI. A total of 237 patients who presented with STEMI were prospectively enrolled. The CMR protocol included left-ventricular ejection fraction (LVEF), late gadolinium enhancement (LGE) and microvascular obstruction (MVO) measurement, and volumetric MBF assessment. During a median follow-up of 2.6 years, 47 patients experienced POCO (primary outcome) and 21 patients had MACE. In a multivariable model, multivessel disease, LGE, MVO, and hyperemic MBF were independently associated with POCO. Addition of hyperemic MBF to the model consisting of GRACE score, multivessel disease, LVEF, LGE, and MVO significantly improved the predictive efficacy (integrated discrimination improvement 0.020, p  = 0.021). Patients with low hyperemic MBF had significantly higher incidence of MACE compared to those with high hyperemic MBF in propensity score matching analysis ( p  = 0.018). In conclusion, CMR-derived hyperemic MBF could provide independent and incremental prognostic value over LVEF, LGE, and MVO in patients with STEMI.</description><identifier>ISSN: 0910-8327</identifier><identifier>EISSN: 1615-2573</identifier><identifier>DOI: 10.1007/s00380-020-01570-8</identifier><identifier>PMID: 32103321</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Aged ; Biomedical Engineering and Bioengineering ; Blood flow ; Cardiac Surgery ; Cardiology ; Coronary Circulation ; Coronary Sinus - diagnostic imaging ; Coronary Sinus - physiopathology ; Female ; Gadolinium ; Heart ; Heart attacks ; Heart Disease Risk Factors ; Humans ; Hyperemia - diagnostic imaging ; Hyperemia - physiopathology ; Magnetic resonance imaging ; Magnetic Resonance Imaging, Cine ; Male ; Medicine ; Medicine &amp; Public Health ; Microvasculature ; Middle Aged ; Myocardial infarction ; Myocardial Perfusion Imaging ; Original Article ; Percutaneous Coronary Intervention ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Risk Assessment ; ST Elevation Myocardial Infarction - diagnostic imaging ; ST Elevation Myocardial Infarction - physiopathology ; ST Elevation Myocardial Infarction - therapy ; Stents ; Treatment Outcome ; Vascular Surgery ; Ventricle</subject><ispartof>Heart and vessels, 2020-07, Vol.35 (7), p.936-945</ispartof><rights>Springer Japan KK, part of Springer Nature 2020</rights><rights>Springer Japan KK, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-2a001b4e79fe4477491ab4e172469a0397be00112acff7396fe8a6eac8945a0b3</citedby><cites>FETCH-LOGICAL-c399t-2a001b4e79fe4477491ab4e172469a0397be00112acff7396fe8a6eac8945a0b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32103321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hamaya, Rikuta</creatorcontrib><creatorcontrib>Kanaji, Yoshihisa</creatorcontrib><creatorcontrib>Hada, Masahiro</creatorcontrib><creatorcontrib>Kanno, Yoshinori</creatorcontrib><creatorcontrib>Usui, Eisuke</creatorcontrib><creatorcontrib>Hoshino, Masahiro</creatorcontrib><creatorcontrib>Yamaguchi, Masao</creatorcontrib><creatorcontrib>Sumino, Yohei</creatorcontrib><creatorcontrib>Horie, Tomoki</creatorcontrib><creatorcontrib>Hirano, Hidenori</creatorcontrib><creatorcontrib>Sugiyama, Tomoyo</creatorcontrib><creatorcontrib>Kakuta, Tsunekazu</creatorcontrib><title>Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction</title><title>Heart and vessels</title><addtitle>Heart Vessels</addtitle><addtitle>Heart Vessels</addtitle><description>The prognostic implications of cardiovascular magnetic resonance imaging (CMR)-derived hyperemic myocardial blood flow (MBF) in patients with ST-elevation myocardial infarction (STEMI) are unknown. This study sought to investigate the incremental prognostic value of hyperemic MBF over conventional CMR markers to identify patients with high risk of future incidence of patient-oriented composite outcomes (POCO) and major adverse cardiac events (MACE) after STEMI. A total of 237 patients who presented with STEMI were prospectively enrolled. The CMR protocol included left-ventricular ejection fraction (LVEF), late gadolinium enhancement (LGE) and microvascular obstruction (MVO) measurement, and volumetric MBF assessment. During a median follow-up of 2.6 years, 47 patients experienced POCO (primary outcome) and 21 patients had MACE. In a multivariable model, multivessel disease, LGE, MVO, and hyperemic MBF were independently associated with POCO. Addition of hyperemic MBF to the model consisting of GRACE score, multivessel disease, LVEF, LGE, and MVO significantly improved the predictive efficacy (integrated discrimination improvement 0.020, p  = 0.021). Patients with low hyperemic MBF had significantly higher incidence of MACE compared to those with high hyperemic MBF in propensity score matching analysis ( p  = 0.018). In conclusion, CMR-derived hyperemic MBF could provide independent and incremental prognostic value over LVEF, LGE, and MVO in patients with STEMI.</description><subject>Aged</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Blood flow</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Coronary Circulation</subject><subject>Coronary Sinus - diagnostic imaging</subject><subject>Coronary Sinus - physiopathology</subject><subject>Female</subject><subject>Gadolinium</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart Disease Risk Factors</subject><subject>Humans</subject><subject>Hyperemia - diagnostic imaging</subject><subject>Hyperemia - physiopathology</subject><subject>Magnetic resonance imaging</subject><subject>Magnetic Resonance Imaging, Cine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Microvasculature</subject><subject>Middle Aged</subject><subject>Myocardial infarction</subject><subject>Myocardial Perfusion Imaging</subject><subject>Original Article</subject><subject>Percutaneous Coronary Intervention</subject><subject>Predictive Value of Tests</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>ST Elevation Myocardial Infarction - diagnostic imaging</subject><subject>ST Elevation Myocardial Infarction - physiopathology</subject><subject>ST Elevation Myocardial Infarction - therapy</subject><subject>Stents</subject><subject>Treatment Outcome</subject><subject>Vascular Surgery</subject><subject>Ventricle</subject><issn>0910-8327</issn><issn>1615-2573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kUtPGzEUha2qqITQP8ACWeqGzbR-zXi8RFEplZCoRFhbHscOjjzjYE-K-Pe96aQUsUDy8_o7x1c6CJ1R8pUSIr8VQnhLKsJg0lqSqv2AZrShdcVqyT-iGVEUipzJY3RSyoYApaj6hI45o4TDMkP5V07rIZUxWBz6bQzWjCENOHm8jqkzEffPyZq8CnDsYkor7GN6wmHAWyDdMBb8FMYHfLesilv3UMAuut-TyyttGLzJdl89RUfexOI-H_Y5ur_6vlxcVze3P34uLm8qy5UaK2ag3044qbwTQkqhqIErlUw0yhCuZOeAoMxY7yVXjXetaZyxrRK1IR2fo4vJd5vT486VUfehWBejGVzaFc140zSCKlYD-uUNukm7PEB3mgkiGyJgAMUmyuZUSnZeb3PoTX7WlOh9InpKREMi-m8iugXR-cF61_Vu9SL5FwEAfAIKPA1rl____Y7tH67Tl0g</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Hamaya, Rikuta</creator><creator>Kanaji, Yoshihisa</creator><creator>Hada, Masahiro</creator><creator>Kanno, Yoshinori</creator><creator>Usui, Eisuke</creator><creator>Hoshino, Masahiro</creator><creator>Yamaguchi, Masao</creator><creator>Sumino, Yohei</creator><creator>Horie, Tomoki</creator><creator>Hirano, Hidenori</creator><creator>Sugiyama, Tomoyo</creator><creator>Kakuta, Tsunekazu</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20200701</creationdate><title>Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction</title><author>Hamaya, Rikuta ; Kanaji, Yoshihisa ; Hada, Masahiro ; Kanno, Yoshinori ; Usui, Eisuke ; Hoshino, Masahiro ; Yamaguchi, Masao ; Sumino, Yohei ; Horie, Tomoki ; Hirano, Hidenori ; Sugiyama, Tomoyo ; Kakuta, Tsunekazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-2a001b4e79fe4477491ab4e172469a0397be00112acff7396fe8a6eac8945a0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Blood flow</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Coronary Circulation</topic><topic>Coronary Sinus - diagnostic imaging</topic><topic>Coronary Sinus - physiopathology</topic><topic>Female</topic><topic>Gadolinium</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart Disease Risk Factors</topic><topic>Humans</topic><topic>Hyperemia - diagnostic imaging</topic><topic>Hyperemia - physiopathology</topic><topic>Magnetic resonance imaging</topic><topic>Magnetic Resonance Imaging, Cine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Microvasculature</topic><topic>Middle Aged</topic><topic>Myocardial infarction</topic><topic>Myocardial Perfusion Imaging</topic><topic>Original Article</topic><topic>Percutaneous Coronary Intervention</topic><topic>Predictive Value of Tests</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>ST Elevation Myocardial Infarction - diagnostic imaging</topic><topic>ST Elevation Myocardial Infarction - physiopathology</topic><topic>ST Elevation Myocardial Infarction - therapy</topic><topic>Stents</topic><topic>Treatment Outcome</topic><topic>Vascular Surgery</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamaya, Rikuta</creatorcontrib><creatorcontrib>Kanaji, Yoshihisa</creatorcontrib><creatorcontrib>Hada, Masahiro</creatorcontrib><creatorcontrib>Kanno, Yoshinori</creatorcontrib><creatorcontrib>Usui, Eisuke</creatorcontrib><creatorcontrib>Hoshino, Masahiro</creatorcontrib><creatorcontrib>Yamaguchi, Masao</creatorcontrib><creatorcontrib>Sumino, Yohei</creatorcontrib><creatorcontrib>Horie, Tomoki</creatorcontrib><creatorcontrib>Hirano, Hidenori</creatorcontrib><creatorcontrib>Sugiyama, Tomoyo</creatorcontrib><creatorcontrib>Kakuta, Tsunekazu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Heart and vessels</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamaya, Rikuta</au><au>Kanaji, Yoshihisa</au><au>Hada, Masahiro</au><au>Kanno, Yoshinori</au><au>Usui, Eisuke</au><au>Hoshino, Masahiro</au><au>Yamaguchi, Masao</au><au>Sumino, Yohei</au><au>Horie, Tomoki</au><au>Hirano, Hidenori</au><au>Sugiyama, Tomoyo</au><au>Kakuta, Tsunekazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction</atitle><jtitle>Heart and vessels</jtitle><stitle>Heart Vessels</stitle><addtitle>Heart Vessels</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>35</volume><issue>7</issue><spage>936</spage><epage>945</epage><pages>936-945</pages><issn>0910-8327</issn><eissn>1615-2573</eissn><abstract>The prognostic implications of cardiovascular magnetic resonance imaging (CMR)-derived hyperemic myocardial blood flow (MBF) in patients with ST-elevation myocardial infarction (STEMI) are unknown. This study sought to investigate the incremental prognostic value of hyperemic MBF over conventional CMR markers to identify patients with high risk of future incidence of patient-oriented composite outcomes (POCO) and major adverse cardiac events (MACE) after STEMI. A total of 237 patients who presented with STEMI were prospectively enrolled. The CMR protocol included left-ventricular ejection fraction (LVEF), late gadolinium enhancement (LGE) and microvascular obstruction (MVO) measurement, and volumetric MBF assessment. During a median follow-up of 2.6 years, 47 patients experienced POCO (primary outcome) and 21 patients had MACE. In a multivariable model, multivessel disease, LGE, MVO, and hyperemic MBF were independently associated with POCO. Addition of hyperemic MBF to the model consisting of GRACE score, multivessel disease, LVEF, LGE, and MVO significantly improved the predictive efficacy (integrated discrimination improvement 0.020, p  = 0.021). Patients with low hyperemic MBF had significantly higher incidence of MACE compared to those with high hyperemic MBF in propensity score matching analysis ( p  = 0.018). In conclusion, CMR-derived hyperemic MBF could provide independent and incremental prognostic value over LVEF, LGE, and MVO in patients with STEMI.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>32103321</pmid><doi>10.1007/s00380-020-01570-8</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0910-8327
ispartof Heart and vessels, 2020-07, Vol.35 (7), p.936-945
issn 0910-8327
1615-2573
language eng
recordid cdi_proquest_miscellaneous_2366641925
source Springer Nature
subjects Aged
Biomedical Engineering and Bioengineering
Blood flow
Cardiac Surgery
Cardiology
Coronary Circulation
Coronary Sinus - diagnostic imaging
Coronary Sinus - physiopathology
Female
Gadolinium
Heart
Heart attacks
Heart Disease Risk Factors
Humans
Hyperemia - diagnostic imaging
Hyperemia - physiopathology
Magnetic resonance imaging
Magnetic Resonance Imaging, Cine
Male
Medicine
Medicine & Public Health
Microvasculature
Middle Aged
Myocardial infarction
Myocardial Perfusion Imaging
Original Article
Percutaneous Coronary Intervention
Predictive Value of Tests
Reproducibility of Results
Retrospective Studies
Risk Assessment
ST Elevation Myocardial Infarction - diagnostic imaging
ST Elevation Myocardial Infarction - physiopathology
ST Elevation Myocardial Infarction - therapy
Stents
Treatment Outcome
Vascular Surgery
Ventricle
title Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T04%3A38%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20implication%20of%20global%20myocardial%20blood%20flow%20in%20patients%20with%20ST-segment%20elevation%20myocardial%20infarction&rft.jtitle=Heart%20and%20vessels&rft.au=Hamaya,%20Rikuta&rft.date=2020-07-01&rft.volume=35&rft.issue=7&rft.spage=936&rft.epage=945&rft.pages=936-945&rft.issn=0910-8327&rft.eissn=1615-2573&rft_id=info:doi/10.1007/s00380-020-01570-8&rft_dat=%3Cproquest_cross%3E2366641925%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c399t-2a001b4e79fe4477491ab4e172469a0397be00112acff7396fe8a6eac8945a0b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2407604604&rft_id=info:pmid/32103321&rfr_iscdi=true